Published: 27 December 2021
Author(s): Giustina De Silvestro, Piero Marson, Massimo La Raja, Anna Maria Cattelan, Gabriella Guarnieri, Jacopo Monticelli, Ivo Tiberio, Andrea Vianello, Giorgio Gandini, Gianluca Gessoni, Francesco Fiorin, Corrado Sardella, Laura Astolfi, Mario Saia, Veneto Hospitals
Issue: March 2022
Section: Original article

Convalescent plasma (CP) has been used worldwide to counteract the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)[1]. Since April 2020, it has also been utilised in the treatment of patients with COVID-19 in the Veneto region (Italy), along with all the other available drugs and therapeutic tools[2].

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness